T 2049/19 (Ticagrelor formulation/ASTRAZENECA) of 23.08.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T204919.20210823
- Date of decision
- 23 August 2021
- Case number
- T 2049/19
- Online on
- 17 December 2021
- Petition for review of
- -
- Application number
- 07794121.9
- IPC class
- A61K 31/519A61K 9/48A61K 9/20
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMPOSITIONS, SUITABLE FOR ORAL ADMINISTRATION, COMPRISING A TRIAZOLO [4, 5-D]PYRIMIDIN DERIVATE
- Applicant name
- AstraZeneca AB
- Opponent name
- Wittkopp, Alexander
Hexal AG
Generics [UK] Limited (trading as Mylan) - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - no (all requests)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.